Nidan Laboratories and Healthcare Limited

NSEI:NIDAN Stok Raporu

Piyasa değeri: ₹425.3m

Nidan Laboratories and Healthcare Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Nidan Laboratories and Healthcare has been growing earnings at an average annual rate of 1.3%, while the Healthcare industry saw earnings growing at 29.2% annually. Revenues have been growing at an average rate of 2.4% per year.

Anahtar bilgiler

1.3%

Kazanç büyüme oranı

-2.1%

EPS büyüme oranı

Healthcare Sektör Büyümesi29.4%
Gelir büyüme oranı2.4%
Özkaynak getirisi-4.9%
Net Marj-13.4%
Son Kazanç Güncellemesi31 Mar 2024

Yakın geçmiş performans güncellemeleri

Recent updates

With EPS Growth And More, Nidan Laboratories and Healthcare (NSE:NIDAN) Makes An Interesting Case

Jul 19
With EPS Growth And More, Nidan Laboratories and Healthcare (NSE:NIDAN) Makes An Interesting Case

Nidan Laboratories and Healthcare (NSE:NIDAN) Will Want To Turn Around Its Return Trends

Jan 20
Nidan Laboratories and Healthcare (NSE:NIDAN) Will Want To Turn Around Its Return Trends

Gelir ve Gider Dağılımı

Nidan Laboratories and Healthcare nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

NSEI:NIDAN Gelir, gider ve kazançlar (INR Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
31 Mar 24242-32490
31 Dec 232310510
30 Sep 2322031530
30 Jun 2323133520
31 Mar 2324335520
31 Dec 2225734480
30 Sep 2227232430
30 Jun 2228927390
31 Mar 2229727390
31 Mar 2120823280
31 Mar 202227420
31 Mar 192062400

Kaliteli Kazançlar: NIDAN is currently unprofitable.

Büyüyen Kar Marjı: NIDAN is currently unprofitable.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: NIDAN is unprofitable, but has reduced losses over the past 5 years at a rate of 1.3% per year.

Büyüme Hızlandırma: Unable to compare NIDAN's earnings growth over the past year to its 5-year average as it is currently unprofitable

Kazançlar vs. Sektör: NIDAN is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (30.6%).


Özkaynak Getirisi

Yüksek ROE: NIDAN has a negative Return on Equity (-4.88%), as it is currently unprofitable.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin